Cholera is an acute intestinal infection caused by the bacterium Vibrio cholerae. It has been a global scourge for centuries and remains endemic in many developing countries today. Cholera research continues to uncover new insights into the disease and improve prevention and treatment efforts. This research paper pdf aims to provide an in-depth review of cholera by discussing the bacterium that causes it, symptoms and diagnosis, transmission pathways, epidemiology and global impact, pathogenesis, current treatments available, and ongoing research areas.
Cholera is caused by the bacteria Vibrio cholerae. There are over 200 serogroups of V. cholerae but only the O1 and O139 serogroups are known to cause epidemic cholera in humans. The main serogroup responsible for the current seventh cholera pandemic and most cholera cases globally is O1. It has two biotypes – classical and El Tor. The classical biotype was responsible for the earlier pandemics but the El Tor biotype has been the predominant cause since the 1960s. Genome sequencing research has revealed that there are significant genetic differences between the two biotypes that influence virulence and adaptation. El Tor is generally less virulent than classical but is better adapted for survival in aquatic environments outside the human host.
The primary symptoms of cholera include profuse, painless, watery diarrhea that can range from small-volume stools to very large-volume stools. This is due to a toxin produced by V. cholerae called cholera toxin that activates adenylate cyclase, increasing intracellular cAMP levels in the intestines. This leads to hypersecretion of chloride ions into the intestinal lumen, following sodium and water. Additional symptoms may include vomiting, leg cramps, thirst, decreased urine output, sunken eyes, rapid heart rate, and low blood pressure in severe cases. Left untreated, cholera can kill within hours due to severe dehydration and electrolyte imbalances. Laboratory diagnosis of cholera involves culturing the bacteria from a stool sample or using rapid diagnostic tests.
Cholera is generally contracted by consuming food or water contaminated with the cholera bacteria. The infectious dose can be as low as 10,000 bacteria. The bacteria mostly spread through the fecal-oral route – from the stool or vomit of an infected individual getting into the mouth of another individual through contaminated water or food. Key points of transmission include unsafe drinking water sources, poor sanitation, unsafe food preparation involving raw foods, and person-to-person contact. Zooplankton and copepods in warm, brackish aquatic environments can act as reservoirs allowing the bacteria to survive between outbreaks. Conditions like poverty, overcrowding, conflict and displacement increase risk of spread.
Cholera remains a major global public health problem, particularly in developing countries with inadequate water treatment, sanitation infrastructure and access to healthcare. It is endemic in over 50 countries worldwide and there are an estimated 1.3 to 4 million cases and 21,000 to 143,000 deaths globally each year according to the WHO. The worst outbreaks tend to occur in Sub-Saharan Africa, South Asia, and Haiti. Recent large outbreaks have occurred in Yemen, Mozambique, and Malaysia. Refugees and displaced populations living in camps are at especially high risk. Climate change is also projected to worsen the global burden of cholera through rising sea levels, warming temperatures and more extreme weather events increasing risks like flooding that can overwhelm water and sanitation systems.
After ingestion into the small intestine, V. cholerae use a type III secretion system to colonize the intestinal epithelium, evade immunity, and produce cholera toxin. The toxin enters intestinal cells and causes the hypersecretion of electrolytes and water through increased levels of cyclic AMP. Loss of body fluids through this osmotic diarrhea causes dehydration and changes in potassium, sodium, and bicarbonate levels that can lead to life-threatening complications without treatment. Rehydration therapy using oral rehydration solution (ORS) is the primary treatment for cholera to replace fluid and electrolyte losses. Antibiotics like doxycycline or azithromycin may also be given to reduce the duration and volume of diarrhea. Zinc supplementation along with ORS can further improve outcomes. Treatment of severe cases often requires intravenous fluids and electrolyte replacements under medical supervision. A cholera vaccine provides 60-90% protection for up to 2 years but is not widely used in endemic areas due to cost and lack of demand. Continued research is still needed to develop more affordable, effective and longer-lasting vaccines.
Cholera remains an important global health issue despite over a century of research into its causative agent, pathogenesis, and treatment methods. It disproportionately impacts vulnerable populations lacking access to clean water and sanitation infrastructure. Future cholera research should focus on developing low-cost point-of-use water treatment methods, affordable and durable vaccines, rapid diagnostic tests, and determining how climate change and other environmental factors are altering global cholera transmission dynamics. Continued epidemiological surveillance and tracking of antimicrobial resistance profiles in different regions are also crucial. Concerted multidisciplinary efforts will be needed to eventually control and hopefully eliminate this deadly waterborne disease.
Andrew Stroud